Lauxera Capital Partners is an independent, international investment fund focused on growth companies in Healthtech, investing capital and expertise to improve the efficiency of the Healthtech system. The firm targets commercial-stage healthtech businesses at the early profitability stage across Europe and North America.
33% of their portfolio is in Consumer. Average disclosed round size is $89.5M (across 4 rounds with reported amounts).
Portfolio
4
Fund Size
—
Top Stage
Series C
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
6 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 OrganOx | Unknown | $142M | Jan 2025 |
 Natural Cycles | Series C | — | May 2024 |
 Lifen | Series C | — | Nov 2021 |
 LUMICKS | Series D | $93M | Apr 2021 |
| LUMICKS | Series D | $93M | Jan 2021 |
| Natural Cycles | Series B | $30M | Jan 2016 |
Top Co-Investors
Headline2 shared
Pura Vida Investments2 shared
T. Rowe Price2 shared
Farallon Capital Management2 shared
Gilde Healthcare2 shared
JPMorgan Chase & Co.1 shared
Point72 Private Investments1 shared
Serena1 shared
Partech Africa1 shared
Creadev1 shared
EQT Ventures1 shared
Sunstone Partners1 shared
Cormorant Asset Management1 shared
HealthQuest Capital1 shared
BGF1 shared
Soleus Capital1 shared
Avidity Partners1 shared
Sofina1 shared
Last updated: 7 September 2026